AG
PHIOW

Advisor Group’s Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 PHIOW Stock Holding History

Advisor Group’s Portfolio PHIOW Stock Details PHIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-150
Closed – – 5447
2019
Q1 		$0 Buy
+150
New +$5 ﹤0.01% 5398

Other funds holding PHIOW

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Advisor Group's PHIOW Position: Q2 2019 in Review

Advisor Group sold out of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) in Q2 2019, closing a stake of 150 shares.

Advisor Group first reported a position in PHIOW in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 4 funds tracked by Wall St. Rank hold PHIOW as of Q2 2019.

  • Advisor Group reported no remaining Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position as of Q2 2019 after selling out during the quarter.
  • Advisor Group sold 150 Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 shares in Q2 2019.
  • Advisor Group first reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in Q1 2019 and held it in 1 quarter.
  • Advisor Group's Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position peaked at $0 in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.